36 results on '"Sacristan JA"'
Search Results
2. Which Nontraditional Outcomes Should Be Measured in Healthcare Decision-Making in Schizophrenia? A Systematic Review
3. PMS103 - Patients’ Preferences for Rheumatoid Arthritis Treatments and their Participation in the Treatment Decision-Making Process. A Systematic Review of the Literature
4. PMD41 THE NATURE OF THE QUALITY-ADJUSTED LIFE YEAR (QALY) CALCULATION
5. PMH10: SUBJECTIVE RESPONSE TO ANTIPSYCHOTIC TREATMENT AND COMPLIANCE IN SCHIZOPHRENIA
6. PMH3: GLOBAL INDEX OF SAFETY (GIS): A NEW INSTRUMENT TO ASSESS DRUG SAFETY: APPLICATION TO A PROSPECTIVE PHARMACOEPIDEMIOLOGICAL STUDY (EFESO)
7. PNH6: ANTIPSYCHOTIC TREATMENT, ADVERSE EVENTS AND HEALTH-RELATED QUALITY OF LIFE
8. MHA4 SSRI Antidepressant Use Patterns and their Relation to Clinical Global Impressions Scores: A Naturalistic Study
9. Patient involvement in clinical research: why, when, and how
10. Do new cancer drugs offer good value for money? The perspectives of oncologists, health care policy makers, patients, and the general population
11. PMC2 A STANDARDIZED EVIDENCE BASED APPROACH TO ASSESS NONTRADITIONAL OUTCOME MEASURES FOR USE IN HEALTH CARE DECISION MAKING: THE DIABETES EXAMPLE
12. PMD23 WHAT IS THE VALUE OF SOCIAL VALUES? THE USELESSNESS OF ASSESSING HEALTH-RELATED QUALITY OF LIFE THROUGH PREFERENCE MEASURES
13. Absence seizures induced by lithium: possible interaction with fluoxetine
14. PIN4 COST-EFFECTIVENESS OF DROTRECOGIN ALFA (ACTIVATED) IN THE TREATMENT OF SEVERE SEPSIS IN SPAIN
15. PCN2: DOSES OF OLANZPINE, RISPERIDONE, AND HALOPERIDOL IN CLINICAL PRACTICE: RESULTS OF A PROSPECTIVE PHARMACOEOPIDEMIOGICAL STUDY (EFESO)
16. QL3: ANTIPSYCHOTIC TREATMENT AND CHANGES IN HEALTH RELATED QUALITY OF LIFE IN PATIENTS WITH SCHIZOPHRENIA USING EQ-5D
17. MHA4SSRI Antidepressant use Patterns and Their Relation to Clinical Global Impressions Scores: A Naturalistic Study
18. Do new cancer drugs offer good value for money? the perspective of oncologists, payers, patients, and general population.
19. SSRI antidepressant use patterns and their relation to clinical global impression scores: a naturalistic study.
20. Economic value of gemcitabine in non-small cell lung cancer.
21. Use of salivary caffeine tests to assess the inducer effect of a drug on hepatic metabolism.
22. Assessment of the time course of drugs with inhibitory effects on hepatic metabolic activity using successive salivary caffeine tests.
23. Should the philosophy of postmarketing surveillance in the US be redefined?
24. [Contracted Medical Research Organizations: is there need for regulation?].
25. Diltiazem treatment impairs theophylline elimination in patients with bronchospastic airway disease.
26. Cerebrospinal fluid concentrations of caffeine following oral drug administration: correlation with salivary and plasma concentrations.
27. Terfenadine-induced tremor.
28. Probable acenocoumarol-amoxycillin interaction.
29. Vancomycin peak concentration and ototoxicity prevention.
30. Pulmonary oedema due to fentanyl?
31. Caffeine concentrations in adult patients chronically taking theophylline.
32. Comparison of a monoclonal antibody fluorescent polarization immunoassay with monoclonal antibody radioimmunoassay for cyclosporin determination in whole blood.
33. Interferon alfa-2a-induced impotence.
34. Interference of digoxin-like immunoreactive substances with TDx digoxin II assay in different patients.
35. Necessity of a loading dose when using vancomycin in critical-ill patients.
36. Absence seizures induced by lithium: possible interaction with fluoxetine.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.